Komori
Nippon Shikizai (4920) · FactRestated

Domestic and Overseas Contract Manufacturing Business Centered on Cosmetics OEM

First written in FY2016. 24 of 29 entries say "Restated". Latest entry: FY2027-H1.

29entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q2 – FY2022RestatedFY2023-Q2 – FY2027-H12016: 120162017: 220172018: 320182019: 320192020: 320202021: 420212022: 420222023: 320232024: 320242025: 120252026: 22026
Same theme, other companies
Cosmetics OEM business utilizing in-house manufacturing technologyA theme 2 companies write about · 0 as a headwind · 2 as a tailwind

0 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1RestatedAnnual report

    「There have been no material changes in the nature of the businesses conducted by the Group (the Company and its affiliated companies) during the interim consolidated accounting period. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  2. FY2026RestatedAnnual report

    「Our principal activities are contract manufacturing and contract research and development for cosmetics, including quasi-drugs. Our consolidated subsidiary THEPENIER PHARMA & COSMETICS S.A.S. (Thepenier) is principally engaged in contract manufacturing of pharmaceuticals and cosmetics in France, while Nippon Shikizai France S.A.S. is principally engaged in contract manufacturing of cosmetics in France.」

    Domestic cosmetics OEM and ODM, together with contract manufacturing by Thepenier and Nippon Shikizai France in France, were reconfirmed as the group’s principal businesses.
  3. FY2026-H1RestatedAnnual report

    「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the interim consolidated accounting period. There were also no changes among its principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  4. FY2025-H1RestatedAnnual report

    「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the interim consolidated accounting period. There were also no changes among its principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  5. FY2025-Q1RestatedAnnual report

    「There were no significant changes in the nature of the businesses conducted by our group, comprising the Company and its affiliated companies, during the cumulative first quarter of the current fiscal year. There were also no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  6. FY2024-Q3RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the nine-month period ended December 31, 20XX. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  7. FY2024-Q2RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the six-month period ended September 30, 20XX. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  8. FY2024-Q1RestatedAnnual report

    「There were no material changes in the nature of the businesses conducted by the Group (the Company and its affiliated companies) during the first quarter of the current consolidated cumulative period. There were also no changes in the Group’s major affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  9. FY2023-Q3RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the nine-month period ended December 31, 20XX. The following changes have occurred among the principal affiliated companies.」

    The absence of significant changes in the nature of the businesses was reconfirmed, while Nippon Shikizai France remained within the scope of consolidation from the first quarter.
  10. FY2023-Q2RestatedAnnual report

    「There were no significant changes in the nature of the businesses conducted by our group, comprising the Company and its affiliated companies, during the cumulative second quarter of the current fiscal year. Changes among the principal affiliated companies were as follows.」

    The absence of significant changes in the nature of the businesses was reconfirmed, while Nippon Shikizai France remained within the scope of consolidation from the first quarter.
  11. FY2023-Q1ReframedAnnual report

    「Nippon Shikizai France S.A.S. has been included in the scope of consolidation from the current first quarter because its significance to our group has increased.」

    Nippon Shikizai France, previously a non-consolidated subsidiary, was brought into the scope of consolidation from the current quarter because its significance had increased, updating the group’s business structure.
  12. FY2022RestatedAnnual report

    「Our principal activities are contract manufacturing and contract research and development for cosmetics, including quasi-drugs. Our consolidated subsidiary THEPENIER PHARMA & COSMETICS S.A.S. (Thepenier) is principally engaged in contract manufacturing of pharmaceuticals and cosmetics in France. Our non-consolidated subsidiary Nippon Shikizai France S.A.S. is principally engaged in contract manufacturing of cosmetics in France.」

    The group’s principal businesses were reconfirmed as domestic cosmetics OEM and ODM, and contract manufacturing by Thepenier and Nippon Shikizai France in France.
  13. FY2022-Q3RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the nine-month period ended December 31, 20XX. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  14. FY2022-Q2RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the six-month period ended September 30, 20XX. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  15. FY2022-Q1RestatedAnnual report

    「There were no material changes in the nature of the businesses conducted by the Group (the Company and its affiliated companies) during the first quarter of the current consolidated cumulative period. There were also no changes in the Group’s major affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  16. FY2021RestatedAnnual report

    「Our principal activities are contract manufacturing and contract research and development for cosmetics, including quasi-drugs. Our consolidated subsidiary THEPENIER PHARMA & COSMETICS S.A.S. (Thepenier) is principally engaged in contract manufacturing of pharmaceuticals and cosmetics in France. Our non-consolidated subsidiary Nippon Shikizai France S.A.S. is principally engaged in contract manufacturing of cosmetics in France.」

    The group’s principal businesses were reconfirmed as domestic cosmetics OEM and contract manufacturing by Thepenier and Nippon Shikizai France in France.
  17. FY2021-Q3RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the nine-month period ended December 31, 20XX. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  18. FY2021-Q2RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the six-month period ended September 30, 20XX. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  19. FY2021-Q1RestatedAnnual report

    「There were no material changes in the nature of the businesses conducted by the Group (the Company and its affiliated companies) during the first quarter of the current consolidated cumulative period. There were also no changes in the Group’s major affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  20. FY2020-Q3RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the nine-month period ended December 31, 20XX. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  21. FY2020-Q2RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the six-month period ended September 30, 20XX. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  22. FY2020-Q1RestatedAnnual report

    「There were no material changes in the nature of the businesses conducted by the Group (the Company and its affiliated companies) during the first quarter of the current consolidated cumulative period. There were also no changes in the Group’s major affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  23. FY2019-Q3RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the nine-month period ended December 31, 20XX. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  24. FY2019-Q2RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the six-month period ended September 30, 20XX. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  25. FY2018ReframedAnnual report

    「Our non-consolidated subsidiary Nippon Shikizai France S.A.S. (Nippon Shikizai France, formerly Orleans Cosmetics S.A.S.) is primarily engaged in contract manufacturing of cosmetics in France.」

    The positioning of the non-consolidated French subsidiary was updated to reflect the change in corporate name from Orleans Cosmetics S.A.S. to Nippon Shikizai France S.A.S. effective 1 March 2018.
  26. FY2018-Q3ReframedAnnual report

    「Although political uncertainty remains, the European economy, where our subsidiary THEPENIER PHARMA & COSMETICS S.A.S. is located, has continued to show solid personal consumption and capital investment, and the economic recovery trend has persisted.」

    Thepenier changed its corporate name to THEPENIER PHARMA & COSMETICS S.A.S. effective 1 January 2018.
  27. FY2018-Q2RestatedAnnual report

    「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the six-month period ended September 30, 20XX. There have also been no changes among the principal affiliated companies.」

    The Company reconfirms that there were no material changes in its business or among its principal affiliated companies.
  28. FY2017ReframedAnnual report

    「Our principal business is contract manufacturing and contract research and development for cosmetics, including quasi-drugs. Our consolidated subsidiary, THEPENIER PHARMA INDUSTRIE S.A.S. (Thepenier), is primarily engaged in contract manufacturing of pharmaceuticals and cosmetics in France. Our non-consolidated subsidiary, Orleans Cosmetics S.A.S. (Orleans Cosmetics), was made a subsidiary of Thepenier, and therefore a sub-subsidiary of the Company, after Thepenier acquired part of its issued shares on 26 January 2017 (local time). Orleans Cosmetics is primarily engaged in contract manufacturing of cosmetics in France.」

    In addition to the existing domestic cosmetics OEM business and Thepenier’s operations in France, Orleans Cosmetics became part of the business structure as a sub-subsidiary.
  29. FY2016First statedAnnual report

    「Our principal business is contract manufacturing and contract research and development for cosmetics, including quasi-drugs. Our subsidiary, THEPENIER PHARMA INDUSTRIE S.A.S. (Thepenier), is primarily engaged in contract manufacturing of pharmaceuticals and cosmetics in France.」

    The group’s principal businesses are described as domestic cosmetics OEM and pharmaceutical and cosmetics contract manufacturing conducted by its French subsidiary.
Moved together

"Increasing uncertainty in the business environment due to overseas economic slowdown and yen appreciation" moved the same way as this thread, in the same document, in 3 of its 29 moves.

322★123
  1. ★This thread
  2. 1Increasing uncertainty in the business environment due to overseas economic slowdown and yen appreciation3×
  3. 2Exposure to interest-rate and foreign-exchange movements2×
  4. 3Risk of shortages of specialist talent and loss of key personnel2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nippon Shikizai yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Domestic and Overseas Contract Manufacturing Business Centered on Cosmetics OEM | Nippon Shikizai,Inc. (4920) | Komori